Another Possible Benefit of SGLT2i’s An interesting sub-analysis was just published in the LANCET, evaluating the impact of canagliflozin on…
I just finished the following review article reviewing the major cardiovascular outcome RCT’s with antihyperglycemics in type 2 diabetes. With…